Just trawling through some old stocks on my watchlist (owned TTR...

Just trawling through some old stocks on my watchlist (owned TTR years ago) and read about the scoping study due shortly. Any idea what a positive (or negative effect) the study will have on the shareprice?

Currently TTR have a market cap of $17m while a nearology stock like QMN has a market cap of $54m and thats without a scoping study. Just seems that there should be room for significant upside if the studies positive. Also the annual report talks about the project in very positive terms and in a manner that indicates it is definetly going ahead.